Opus Genetics, Inc. Contract Liability (Deferred Revenue)
Opus Genetics, Inc. (IRD) had Contract Liability (Deferred Revenue) of $650.00 thousand as of 2020-09-30, per its 10-Q filed 2020-10-29.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2020-10-29
- 2020-09-30: Contract with Customer, Liability, Current $650.00K.
- 2020-06-30: Contract with Customer, Liability, Current $650.00K.
- 2020-03-31: Contract with Customer, Liability, Current $600.00K.
- 2019-12-31: Contract with Customer, Liability, Current $1.50M.
| Period end | Contract with Customer, Liability, Current |
|---|---|
| 2020-09-30 | $650.00K 10-Q · filed 2020-10-29 |
| 2020-06-30 | $650.00K 10-Q · filed 2020-08-14 |
| 2020-03-31 | $600.00K 10-Q · filed 2020-05-07 |
| 2019-12-31 | $1.50M 10-Q · filed 2020-10-29 |
| 2019-09-30 | $1.50M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $1.50M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $150.00K 10-Q · filed 2019-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |